Research Assistant Professor in Urology, Northwestern University Medical School
Urology
Dr. Brian T. Helfand, MD
|
|
Give Review
Brian Helfand works in the field of Urology. He graduated from Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification". Doctor Brian T. Helfand, MD is also a published physician. He has 82 publication published. The most recent publication is: Multifetal reduction increases the risk of preterm delivery and fetal growth restriction in twins: a case-control study. Brian Helfand accepts Medicare payments and is listed with Medicare.gov.
Publications
- Mutational landscape of aggressive prostate tumors in African American men.
- Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer.
- Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
- A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.
- A genetic-based approach to personalized prostate cancer screening and treatment.
- Penile fracture: outcomes of early surgical intervention.
- Are We Testing Appropriately for Low Testosterone?: Characterization of Tested Men and Compliance with Current Guidelines.
- Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database.
- Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.
- The Epidemiology and Clinical Implications of Genetic Variation in Prostate Cancer.
- Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.
- The use of adhesion barrier film as an alternative to omental wrap in open ureterolysis.
- Prostate cancer risk alleles are associated with prostate cancer tumor volume and prostate size.
- Personalized Prostate Specific Antigen Testing Using Genetic Variants May Reduce Unnecessary Prostate Biopsies.
- Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy.
- Associations Between Improvements in Lower Urinary Tract Symptoms and Sleep Disturbance Over Time in the CAMUS Trial.
- Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility.
- Influences of neuroregulatory factors on the development of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction in aging men.
- Screening urine analysis before bacille Calmette-Guérin instillation does not reduce the rate of infectious complications.
- Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance.
- Chromosomal Regions Associated with Prostate Cancer Risk Localize to Lamin B Deficient Microdomains and Exhibit Reduced Gene Transcription.
- Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
- Prostate Cancer Risk Alleles and Their Associations With Other Malignancies.
- Delay of surgery in men with low risk prostate cancer.
- Simple Modifications in Operating Room Processes to Reduce the Times and Costs Associated with Robot-Assisted Laparoscopic Radical Prostatectomy.
- Vimentin organization modulates the formation of lamellipodia.
- Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.
- Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specifi...
- Vena cava thrombectomy and primary repair after radical nephrectomy for renal cell carcinoma: single-center experience.
- TGF-? Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence.
- Genetic correction of PSA values using sequence variants associated with PSA levels.
- Determining the utility of recalled lower urinary tract symptoms.
- Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.
- Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity.
- Medications and surgical interventions for benign prostatic hyperplasia are potential confounders of prostate-specific antigen.
- Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?
- Established medical therapy for benign prostatic hyperplasia.
- Fetal pyelectasis as predictor of decreased differential renal function.
- Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.
- Pseudodistal ureteral stone resulting from calcified Deflux implantation.
- Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.
- Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
- Pathological outcomes associated with the 17q prostate cancer risk variants.
- Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.
- Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prost...
- Ureterovaginal fistula formation after oocyte retrieval.
- Complications of open radical retropubic prostatectomy in potential candidates for active monitoring.
- Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles.
- Retrieval of migrated ureteral stents by coaxial cannulation with a flexible ureteroscope and paired helical basket.
- Comparison of prostate specific antigen velocity in screened versus referred patients with prostate cancer.
- Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.
- A role for intermediate filaments in determining and maintaining the shape of nerve cells.
- A specific mechanism of nonspecific inhibition.
- The dynamic and motile properties of intermediate filaments.
- A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organization.
- Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
- Outcomes of lateral retroperitoneal reservoir placement of three-piece penile prosthesis in patients following radical prostatectomy.
- Multifetal reduction increases the risk of preterm delivery and fetal growth restriction in twins: a case-control study.
- Fast transport of neurofilament protein along microtubules in squid axoplasm.
- New horizons in cytoskeletal dynamics: transport of intermediate filaments along microtubule tracks.
- Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study.
- A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.
- The relationship between lower urinary tract symptom severity and sleep disturbance in the CAMUS trial.
- Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.
- Clear cell renal cell carcinoma with osseous metaplasia: a case report.
- Reconstruction of late-onset transplant ureteral stricture disease.
- A comparison of the frequencies of medical therapies for overactive bladder in men and women: analysis of more than 7.2 million aging patients.
- Number of prostate cancer risk alleles may identify possibly ''insignificant'' disease.
- Holmium laser ablation and enucleation of the prostate: a pilot study of the hybrid technique.
- Is statin use associated with prostate cancer aggressiveness?
- Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?
- Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trial.
- Holmium laser prostatic resection for patients presenting with acute urinary retention.
- Reconstruction of urethral erosion in men with a neurogenic bladder.
- Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease.
- Intermediate filaments are dynamic and motile elements of cellular architecture.
- Intermediate filament proteins participate in signal transduction.
- Rapid transport of neural intermediate filament protein.
- Tropomyosins are present in lamellipodia of motile cells.
- Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
- Introducing intermediate filaments: from discovery to disease.
Schools
Nwu Feinberg Sch Of Med
McGaw Medical Center Of Northwestern Unversity
Northwestern University Feinberg School Of Medicine
Procedures Preformed
- Adrenalectomy
- Advanced Laparoscopic Surgery
- Bladder Biopsy
- Circumcision
- View All
Doctors Specialties
- Oncology
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
McGaw Medical Center of Northwestern University -
Northwestern University Feinberg School of Medicine
Hospital
-
Northwestern Memorial Hospital
Drug Facts
| NPI NUMBER | 1851551782 | |
| NPPES Provider LastName | HELFAND | |
| NPPES Provider FirstName | BRIAN | |
| NPPES Provider ZIPCode | 606114296 | |
| NPPES Provider State | IL | |
| Specialty Description | Urology | |
| Total Claim Count | 427.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 4.22 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851551782 |
| Last Name Of The Provider | HELFAND |
| First Name Of The Provider | BRIAN |
| View All |
Similar Doctors
|
Dr. Charles B. Brendler, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Amanda M. Macejko, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kristian R. Novakovic, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William A. Cook, MD |
|
|
Dr. Charles M. Feinstein, MD
This Doctor is OpenDoctor Recommended.
|